Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS.

Thompson AJ, Kennard C, Swash M, Summers B, Yuill GM, Shepherd DI, Roche S, Perkin GD, Loizou LA, Ferner R, et al.

Neurology. 1989 Jul;39(7):969-71.

PMID:
2544829
2.

Intravenous methylprednisolone for multiple sclerosis in relapse.

Barnes MP, Bateman DE, Cleland PG, Dick DJ, Walls TJ, Newman PK, Saunders M, Tilley PJ.

J Neurol Neurosurg Psychiatry. 1985 Feb;48(2):157-9.

3.

[Therapeutic indications for acute episodes of multiple sclerosis].

Brochet B.

Rev Neurol (Paris). 2001 Sep;157(8-9 Pt 2):988-95. Review. French.

PMID:
11787365
4.

Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom.

Tremlett HL, Luscombe DK, Wiles CM.

J Neurol Neurosurg Psychiatry. 1998 Sep;65(3):362-5.

5.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
6.

"Bolus" methylprednisolone versus ACTH in the treatment of multiple sclerosis.

Abbruzzese G, Gandolfo C, Loeb C.

Ital J Neurol Sci. 1983 Jun;4(2):169-72.

PMID:
6311774
7.

Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose.

Alam SM, Kyriakides T, Lawden M, Newman PK.

J Neurol Neurosurg Psychiatry. 1993 Nov;56(11):1219-20.

8.
9.

Corticosteroids and multiple sclerosis.

Miller DH.

J Neurol Neurosurg Psychiatry. 1998 Sep;65(3):290. No abstract available.

10.

High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations.

Durelli L, Cocito D, Riccio A, Barile C, Bergamasco B, Baggio GF, Perla F, Delsedime M, Gusmaroli G, Bergamini L.

Neurology. 1986 Feb;36(2):238-43.

PMID:
3511404
11.

Double-blind randomized trial of ACTH versus dexamethasone versus methylprednisolone in multiple sclerosis bouts. Clinical, cerebrospinal fluid and neurophysiological results.

Milanese C, La Mantia L, Salmaggi A, Campi A, Eoli M, Scaioli V, Nespolo A, Corridori F.

Eur Neurol. 1989;29(1):10-4.

PMID:
2540005
12.

[Steroid therapy for multiple sclerosis].

Oishi C, Sakuta M.

Nihon Rinsho. 2003 Aug;61(8):1361-6. Review. Japanese.

PMID:
12962024
13.

Acute improvement in exacerbating multiple sclerosis produced by intravenous administration of mannitol.

Stefoski D, Davis FA, Schauf CL.

Ann Neurol. 1985 Oct;18(4):443-50.

PMID:
3000278
15.

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.

Milligan NM, Newcombe R, Compston DA.

J Neurol Neurosurg Psychiatry. 1987 May;50(5):511-6.

16.

The effect of oral and intravenous methylprednisolone treatment on subsequent relapse rate in multiple sclerosis.

Sharrack B, Hughes RA, Morris RW, Soudain S, Wade-Jones O, Barnes D, Brown P, Britton T, Francis DA, Perkin GD, Rudge P, Swash M, Katifi HA, Farmer S, Frankel JP.

J Neurol Sci. 2000 Feb 1;173(1):73-7.

PMID:
10675582
17.

[Steroid therapy in multiple sclerosis].

Beer S, Kesselring J.

Schweiz Med Wochenschr. 1991 Jun 29;121(26):961-9. Review. German.

PMID:
1650496
18.

Randomized trial comparing two different high doses of methylprednisolone in MS: a clinical and MRI study.

Oliveri RL, Valentino P, Russo C, Sibilia G, Aguglia U, Bono F, Fera F, Gambardella A, Zappia M, Pardatscher K, Quattrone A.

Neurology. 1998 Jun;50(6):1833-6.

PMID:
9633736
19.
20.

High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect.

Miller DH, Thompson AJ, Morrissey SP, MacManus DG, Moore SG, Kendall BE, Moseley IF, McDonald WI.

J Neurol Neurosurg Psychiatry. 1992 Jun;55(6):450-3.

Items per page

Supplemental Content

Write to the Help Desk